life scienc tool diagnost
ep ahead consensu ep handili beat
better revenu profit rais narrow
ep guidanc midpoint vs con
fulli reflect beat increment headwind fx estimate
higher tax rate importantli maintain intern sale growth
guidanc rais ep
upsid partial off-set fx tax headwind tp move
ebitda higher view
consum shortfal equip rebound profit revenu
declin ex-met ahead plan intern growth
vs estimate includ estimate impact one less sell
day driven technolog vs estimate reflect innov
primescan benefit destock million
hand consum growth vs estimate disappoint
despit easi comp intern sale us rose
vs estimate row rose vs estimate well
view meanwhil europ vs estimate anem oper
margin expand bp bp view flow million
fund million dividend
pre-cal view reiter outperform xray share ralli
ytd vs expect momentum continu
latest upsid particularli encourag healthi
oper margin expans help allevi skeptic lt
target said consum notabl lacklust await
greater call commentari underli geograph dynam read-
broader dental demand trend broadli task
hand daunt term lt growth aspir cost
structur complex see opportun meaning turnaround
aggress restructur plan place reiter
outperform risk includ demand shift execut
valuat metric
number share
price month
 close
suiss seek busi compani cover research report result investor awar
firm may conflict interest could affect object report investor consid report
singl factor make invest decis
dentspli design develop manufactur market
price may rate outperform target price analyst erin wright
profit tax
chang work capit
flow oper
free cash-flow firm
flow invest
chang net cash/debt
total liabil equiti
share wtd average
price book
roe stated-return
better fundament perform sentiment could drive upsid
target price blue sky scenario
weaker fundament perform sentiment could lead
downsid versu target price grey sky scenario
 close
charl martineau pm univers toronto compani mention price
